SGI
1.11
59.7%
GUM
0.14
-22.2%
8IH
0.028
55.6%
MRD
0.038
-20.8%
ALM
0.009
50%
MMR
0.004
-20%
M2R
0.003
50%
RKB
0.004
-20%
LML
0.011
37.5%
RLG
0.004
-20%
QXR
0.004
33.3%
X2M
0.012
-20%
RNX
0.004
33.3%
D3E
0.325
-19.8%
NVA
1.145
33.1%
AUV
0.016
-15.8%
VBS
0.265
32.5%
AVW
0.011
-15.4%
FBM
0.056
30.2%
CC9
0.17
-15%
SDV
0.475
28.4%
PVT
0.017
-15%
AON
0.01
25%
CYQ
0.006
-14.3%
CAV
0.005
25%
DTI
0.012
-14.3%
ENT
0.005
25%
VKA
0.006
-14.3%
FBR
0.005
25%
ATR
0.7
-12.5%
TMX
0.005
25%
NNL
0.19
-11.6%
TMB
0.11
20.9%
DTM
0.04
-11.1%
ZNO
0.076
20.6%
FIN
0.008
-11.1%
OMX
0.1
20.5%
PIM
0.08
-11.1%
BLU
0.006
20%
TEM
0.008
-11.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BlinkLab (ASX:BB1): Creating better tests to diagnose various neurodevelopmental conditions

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, BlinkLab’s (ASX:BB1) Non-Executive Chairman Brian Leedman speaks with The Stock Network’s Lel Smits about:

📱 BlinkLab’s autism diagnostic test, technology development and near priorities
📱 Technology features and potential commercial outcomes

Watch the full interview ⚡️ https://www.youtube.com/watch?v=t7z7g9kUTvA
Register to attend Australian Equities Day: https://www.eventbrite.sg/e/spark-plus-australian-equities-day-tickets-939180011697